Consensus Artivion, Inc.

Equities

AORT

US2289031005

Market Closed - Nyse 04:00:02 2024-06-06 pm EDT 5-day change 1st Jan Change
23.65 USD +0.90% Intraday chart for Artivion, Inc. -0.84% +32.27%

Evolution of the average Target Price on Artivion, Inc.

Price target over the last 5 years

History of analyst recommendation changes

8561ab92.5zDtiWg3zee4q3eEPKxQ4LUJX_kAlAz6RkKbYLqawL4.rgG_wl1ngr3bzhLGeJU0pe08NJM12HWLAhbUUvDojseRR9z8Dk-XjfD9GA~defe7dbe60d9a61cffc45d4d9b5f869d
Stifel Adjusts Price Target on Artivion to $25 From $22, Maintains Buy Rating MT
Needham Adjusts Price Target on Artivion to $30 From $25, Maintains Buy Rating MT
Stifel Raises Price Target on Artivion to $22 From $20, Maintains Buy Rating MT
Morgan Stanley Adjusts Price Target on Artivion to $15 From $14, Maintains Equal-Weight Rating MT
Needham Adjusts Price Target on Artivion to $26 From $23, Maintains Buy Rating MT
Needham Adjusts Price Target on Artivion to $23 From $28, Maintains Buy Rating MT
Morgan Stanley Trims Artivion's Price Target to $14 From $16, Reiterates Equalweight Rating MT
Oppenheimer Adjusts Artivion's Price Target to $25 From $35, Maintains Outperform Rating MT
Morgan Stanley Adjusts Artivion's Price Target to $16 from $23, Maintains Equalweight Rating MT
Oppenheimer Adjusts Artivion Price Target to $25 From $35, Maintains Outperform Rating MT
Needham Trims Artivion's Price Target to $28 From $29, Reiterates Buy Rating MT
Morgan Stanley Adjusts Artivion's Price Target to $21 from $23, Keeps Equalweight Rating MT
Needham Trims Artivion's Price Target to $29 From $30, Reiterates Buy Rating MT
Stifel Starts Artivion at Buy With $30 Price Target MT
Needham Adjusts Artivion's Price Target to $30 From $39 on 'Peer Multiple Compression;' Buy Rating Kept MT
Morgan Stanley Lowers Price Target for CryoLife to $25 From $29, Maintains Equalweight Rating MT
CRYOLIFE : Needham Adjusts CryoLife's Price Target to $39 From $38, Maintains Buy Rating MT
CRYOLIFE : Morgan Stanley Starts CryoLife at Equal-Weight With $31 Price Target MT
CRYOLIFE : Oppenheimer Adjusts CryoLife PT to $35 From $29, Maintains Outperform Rating MT
CRYOLIFE : Needham Adjusts CryoLife's Price Target to $38 From $33, Maintains Buy Rating MT
CRYOLIFE : Oppenheimer Adjusts CryoLife PT to $29 From $25, Maintains Outperform Rating MT
CRYOLIFE : Needham Adjusts CryoLife's Price Target to $28 from $29, Maintains Buy Rating MT
CryoLife Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2016; Revises Earnings Guidance for the Year 2016; Provides Tax Rate Guidance for the Fourth Quarter of 2016 CI
CryoLife Inc. Announces Earnings Results for the First Quarter Ended March 31, 2016; Provides Effective Tax Rate for Balance of the Year; Reiterates Earnings Guidance for the Full Year of 2016 CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
23.65 USD
Average target price
26.75 USD
Spread / Average Target
+13.11%
High Price Target
30 USD
Spread / Highest target
+26.85%
Low Price Target
25 USD
Spread / Lowest Target
+5.71%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Artivion, Inc.

Stifel Nicolaus
Needham & Co.
Morgan Stanley
Oppenheimer
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
  1. Stock Market
  2. Equities
  3. AORT Stock
  4. Consensus Artivion, Inc.